Similar articles for PMID: 34446454

Year	Number of Results
2014	1
2015	7
2016	18
2017	24
2018	17
2019	14
2020	15
2021	17
2022	19
2023	9
2024	0

1

Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT-Derived Total Molecular Tumor Volume.

Seifert R, Sandach P, Kersting D, Fendler WP, Hadaschik B, Herrmann K, Sunderland JJ, Pollard JH. Seifert R, et al. J Nucl Med. 2022 May;63(5):746-753. doi: 10.2967/jnumed.121.262528. Epub 2021 Aug 26. J Nucl Med. 2022. PMID: 34446454 Free PMC article.

2

Quantitative Test-Retest Measurement of ⁶⁸Ga-PSMA-HBED-CC in Tumor and Normal Tissue.

Pollard JH, Raman C, Zakharia Y, Tracy CR, Nepple KG, Ginader T, Breheny P, Sunderland JJ. Pollard JH, et al. J Nucl Med. 2020 Aug;61(8):1145-1152. doi: 10.2967/jnumed.119.236083. Epub 2019 Dec 5. J Nucl Med. 2020. PMID: 31806776 Free article. Clinical Trial.

3

Repeatability of Quantitative ¹⁸F-DCFPyL PET/CT Measurements in Metastatic Prostate Cancer.

Jansen BHE, Cysouw MCF, Vis AN, van Moorselaar RJA, Voortman J, Bodar YJL, Schober PR, Hendrikse NH, Hoekstra OS, Boellaard R, Oprea-Lager DE. Jansen BHE, et al. J Nucl Med. 2020 Sep;61(9):1320-1325. doi: 10.2967/jnumed.119.236075. Epub 2020 Jan 10. J Nucl Med. 2020. PMID: 31924729 Free PMC article. Clinical Trial.

4

Combined Early and Late [⁶⁸Ga]PSMA-HBED-CC PET Scans Improve Lesion Detectability in Biochemical Recurrence of Prostate Cancer with Low PSA Levels.

Hohberg M, Kobe C, Täger P, Hammes J, Schmidt M, Dietlein F, Wild M, Heidenreich A, Drzezga A, Dietlein M. Hohberg M, et al. Mol Imaging Biol. 2019 Jun;21(3):558-566. doi: 10.1007/s11307-018-1263-2. Mol Imaging Biol. 2019. PMID: 30105521

5

High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with ¹⁸F-DCFPyL.

Werner RA, Habacha B, Lütje S, Bundschuh L, Higuchi T, Hartrampf P, Serfling SE, Derlin T, Lapa C, Buck AK, Essler M, Pienta KJ, Eisenberger MA, Markowski MC, Shinehouse L, AbdAllah R, Salavati A, Lodge MA, Pomper MG, Gorin MA, Bundschuh RA, Rowe SP. Werner RA, et al. Mol Imaging. 2022 Feb 23;2022:7056983. doi: 10.1155/2022/7056983. eCollection 2022. Mol Imaging. 2022. PMID: 35283693 Free PMC article. Clinical Trial.

6

68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.

Schmidkonz C, Cordes M, Goetz TI, Prante O, Kuwert T, Ritt P, Uder M, Wullich B, Goebell P, Bäuerle T. Schmidkonz C, et al. Ann Nucl Med. 2019 Oct;33(10):766-775. doi: 10.1007/s12149-019-01387-0. Epub 2019 Jul 23. Ann Nucl Med. 2019. PMID: 31338731

7

⁶⁸Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.

Schmidkonz C, Cordes M, Schmidt D, Bäuerle T, Goetz TI, Beck M, Prante O, Cavallaro A, Uder M, Wullich B, Goebell P, Kuwert T, Ritt P. Schmidkonz C, et al. Eur J Nucl Med Mol Imaging. 2018 Oct;45(11):1862-1872. doi: 10.1007/s00259-018-4042-z. Epub 2018 May 3. Eur J Nucl Med Mol Imaging. 2018. PMID: 29725716

8

Initial Experience with Volumetric ⁶⁸Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.

Schmuck S, von Klot CA, Henkenberens C, Sohns JM, Christiansen H, Wester HJ, Ross TL, Bengel FM, Derlin T. Schmuck S, et al. J Nucl Med. 2017 Dec;58(12):1962-1968. doi: 10.2967/jnumed.117.193581. Epub 2017 May 18. J Nucl Med. 2017. PMID: 28522740 Free article.

9

Semi-automatic evaluation of baseline whole-body tumor burden as an imaging biomarker of ⁶⁸Ga-PSMA-11 PET/CT in newly diagnosed prostate cancer.

Zou Q, Jiao J, Zou MH, Li MZ, Yang T, Xu L, Zhang Y. Zou Q, et al. Abdom Radiol (NY). 2020 Dec;45(12):4202-4213. doi: 10.1007/s00261-020-02745-7. Epub 2020 Sep 18. Abdom Radiol (NY). 2020. PMID: 32948911

10

More advantages in detecting bone and soft tissue metastases from prostate cancer using ¹⁸F-PSMA PET/CT.

Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Pianou NK, et al. Hell J Nucl Med. 2019 Jan-Apr;22(1):6-9. doi: 10.1967/s002449910952. Epub 2019 Mar 7. Hell J Nucl Med. 2019. PMID: 30843003 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

111 results

Results by year